If I Had A Nickel For Every Buying Opportunity…

The path to being a good investor is to be able to see what the future holds and place your bets accordingly. If you...

Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer...

Tailwinds' Take: this is the third VA hospital to join the Cchek study. This demonstrates the success the diagnostic must be showing in other...

Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology

SAN JOSE, Calif., July 24, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight...

Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins...

SAN JOSE, Calif., July 22, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer,...

Anixa Update Call Full Transript

Operator:Good day, everyone. Welcome to today’s corporate update and discussion of recent alliance with Cleveland Clinic on breast cancer vaccine. At this time, all...

Anixa Licenses Another Potential Blockbuster

In January we proclaimed Anixa to be Tailwinds’ stock of the year. This designation was awarded due to potential major milestones in the both...

Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an...

SAN JOSE, Calif., July 17, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that...

Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived...

Tailwinds' Take: This is a very technical study, but here are key points: 1. George Dominguez and Amit Kumar from Anixa are co-authors with the scientists at...

A Shallow Dive From The Deep South

In what is shaping up as a never-ending quest to provide newsletter coverage from anyplace not named "home", this week's letter comes from Raleigh,...

Three Thoughts on Anixa’s S-3

This afternoon Anixa (ANIX) filed a mixed-shelf offering of up to $100M in securities. Included in this was a sales agreement with B. Riley...

Markets Trade Down In May…June Preview

I'm not sure why, but it seems that every time I feel the Tailwinds' Portfolio is poised for big gains, the market enters a...

A Brief Update on Anixa

Yesterday I had the opportunity to sit down with Anixa’s Dr. Amit Kumar, CEO, and Michael Catelani, CFO. Our discussion was rather wide ranging...

Anixa Biosciences to Present at the CYTO 2019 – 34th Congress of the ...

Tailwinds' Take: additional data from the ongoing ResearchDx partnership, which is intended to certify Cchek as a CLIA approved diagnostic, will be presented. Anixa...

B Riley, Day Two Recap

Day two of B Riley was a slightly abbreviated day for yours truly as I had a flight to catch. I did manage to...

Anixa Biosciences Announces Completion of Cchek™ Analytical Verification at CLIA Laboratory

Tallwinds' Take: this important milestone has been achieved within the expected development timeline and Cchek is on track for a Q3 launch. With more...

Bernie Shakes Up Biotech; Anixa Insider Takes Advantage

As the pre-election momentum builds around "MediCare For All", healthcare stocks have become quite jittery. Drug stocks, and in particular the biotech companies, have...

US Patent & Trademark Office Issues Patent on Anixa Biosciences CAR-T Cancer Treatment Technology

Tailwinds' Take: this is a very positive step for Anixa as it insures that they have rights to this treatment as a platform for...

Anixa Biosciences Extends and Expands its Collaboration with New Jersey Urology

Tailwinds' Take: I believe investors don't quite get the lack of support for the PSA in the medical community. Cchek, if and when approved,...

Anixa Biosciences Presents Cchek™ Prostate Cancer Detection Data at AACR Annual Meeting

SAN JOSE, Calif., April 3, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to...

Anixa’s CEO to Present at Major Cancer Symposium

On May 15th, Dr. Amit Kumar will be on a panel discussing cancer therapies for solid tumors. This panel is at a conference hosted...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.